SCHEMBL29152852

SCHEMBL29152852

Clc1cc(C2CCC2)nc2ccnn12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 2/20 0.57
▸ CDK2 P24941 4/20 0.50
▸ CCNA2 P20248 2/20 0.50
▸ CCNA1 P78396 2/20 0.50
▸ CHEK1 O14757 1/20 0.50
▸ CDK9 P50750 4/20 0.41
▸ CCNT1 O60563 3/20 0.41
▸ RAD52 P43351 1/20 0.37
▸ CRHR1 P34998 1/20 0.35
▸ KCNN3 Q9UGI6 3/20 0.35
▸ KCNN1 Q92952 1/20 0.35
▸ KCNN2 Q9H2S1 1/20 0.35
▸ DGAT1 O75907 1/20 0.35
▸ DPP4 P27487 4/20 0.34
▸ CDK7 P50613 3/20 0.34
▸ CDK4 P11802 2/20 0.34
▸ CCND1 P24385 2/20 0.34
▸ CCNH P51946 2/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ CCNE1 P24864 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8573496 0.97 PDE10A (0.57) PDE10ACDK2CCNA2CCNA1CHEK1
SCHEMBL5466448 0.95 PDE10A (0.56) PDE10ACDK2CCNA2CCNA1CHEK1
SCHEMBL1022442 0.86 PDE10A (0.53) PDE10ACDK2CCNA2CCNA1CHEK1
SCHEMBL14413740 0.84 CHEK1 (0.73) PDE10ACDK2CCNA2CCNA1CHEK1
SCHEMBL7880188 0.82 PDE10A (0.46) PDE10ACDK2CCNA2CCNA1CHEK1
SCHEMBL13117265 0.82 PDE10A (0.51) PDE10ACDK2CCNA2CCNA1CHEK1
SCHEMBL14043377 0.82 PDE10A (0.51) PDE10ACDK2CCNA2CCNA1CHEK1
SCHEMBL16086901 0.82 PDE10A (0.48) PDE10ACDK2CCNA2CCNA1CHEK1
SCHEMBL584212 0.82 PDE10A (0.48) PDE10ACDK2CCNA2CCNA1CHEK1
SCHEMBL29152851 0.81 CDK2 (0.50) PDE10ACDK2CCNA2CCNA1CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117486885-A Use of pyrazolopyrimidines 中国科学院上海药物研究所 2024-02-02 — — CN disclosed
Send feedback